McCormick F - Search Results

1

Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies.

Rauen KA, Banerjee A, Bishop WR, Lauchle JO, McCormick F, McMahon M, Melese T, Munster PN, Nadaf S, Packer RJ, Sebolt-Leopold J, Viskochil DH. Rauen KA, et al. Among authors: mccormick f. Am J Med Genet C Semin Med Genet. 2011 May 15;157C(2):136-46. doi: 10.1002/ajmg.c.30294. Epub 2011 Apr 14. Am J Med Genet C Semin Med Genet. 2011. PMID: 21495172 Free PMC article.

2

Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.

Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, McMahon M, Oren M, McCormick F. Ries S, et al. Among authors: mccormick f. Cell. 2000 Oct 13;103(2):321-30. doi: 10.1016/s0092-8674(00)00123-9. Cell. 2000. PMID: 11057904 Free article.

3

Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy.

Rauen KA, Sudilovsky D, Le JL, Chew KL, Hann B, Weinberg V, Schmitt LD, McCormick F. Rauen KA, et al. Among authors: mccormick f. Cancer Res. 2002 Jul 1;62(13):3812-8. Cancer Res. 2002. PMID: 12097294

4

Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells.

Anders M, Christian C, McMahon M, McCormick F, Korn WM. Anders M, et al. Among authors: mccormick f. Cancer Res. 2003 May 1;63(9):2088-95. Cancer Res. 2003. PMID: 12727824

5

Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.

Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, Conger BA, Cruz MS, McCormick F, Rauen KA. Rodriguez-Viciana P, et al. Among authors: mccormick f. Science. 2006 Mar 3;311(5765):1287-90. doi: 10.1126/science.1124642. Epub 2006 Jan 26. Science. 2006. PMID: 16439621

6

Cancer targets in the Ras pathway.

Rodriguez-Viciana P, Tetsu O, Oda K, Okada J, Rauen K, McCormick F. Rodriguez-Viciana P, et al. Among authors: mccormick f. Cold Spring Harb Symp Quant Biol. 2005;70:461-7. doi: 10.1101/sqb.2005.70.044. Cold Spring Harb Symp Quant Biol. 2005. PMID: 16869784 Review.

7

Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options.

Senawong T, Phuchareon J, Ohara O, McCormick F, Rauen KA, Tetsu O. Senawong T, et al. Among authors: mccormick f. Hum Mol Genet. 2008 Feb 1;17(3):419-30. doi: 10.1093/hmg/ddm319. Epub 2007 Nov 2. Hum Mol Genet. 2008. PMID: 17981815

8

Mutation analysis of BRAF, MEK1 and MEK2 in 15 ovarian cancer cell lines: implications for therapy.

Estep AL, Palmer C, McCormick F, Rauen KA. Estep AL, et al. Among authors: mccormick f. PLoS One. 2007 Dec 5;2(12):e1279. doi: 10.1371/journal.pone.0001279. PLoS One. 2007. PMID: 18060073 Free PMC article.

9

Molecular aspects, clinical aspects and possible treatment modalities for Costello syndrome: Proceedings from the 1st International Costello Syndrome Research Symposium 2007.

Rauen KA, Hefner E, Carrillo K, Taylor J, Messier L, Aoki Y, Gripp KW, Matsubara Y, Proud VK, Hammond P, Allanson JE, Delrue MA, Axelrad ME, Lin AE, Doyle DA, Kerr B, Carey JC, McCormick F, Silva AJ, Kieran MW, Hinek A, Nguyen TT, Schoyer L. Rauen KA, et al. Among authors: mccormick f. Am J Med Genet A. 2008 May 1;146A(9):1205-17. doi: 10.1002/ajmg.a.32276. Am J Med Genet A. 2008. PMID: 18412122 No abstract available.

10

Ras signaling and therapies.

Young A, Lyons J, Miller AL, Phan VT, Alarcón IR, McCormick F. Young A, et al. Among authors: mccormick f. Adv Cancer Res. 2009;102:1-17. doi: 10.1016/S0065-230X(09)02001-6. Adv Cancer Res. 2009. PMID: 19595305 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

599 results

Search Page

Filters